From Molecules to Medicine: Nanotechnology Transforming Modern Therapeutics

Authors

  • Shiv Kumar Srivastava Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119 https://orcid.org/0000-0002-8356-2767
  • Mahesh Prasad Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119 https://orcid.org/0000-0001-7329-188X
  • Shashi Shankar Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119 https://orcid.org/0009-0000-0336-0659
  • Anant Prakash Pandey Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119 https://orcid.org/0009-0005-9255-1786
  • Antesh Kumar Jha Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119 https://orcid.org/0000-0002-8742-8215

Abstract

Nanotechnology, the manipulation of matter at the molecular and nanometer scale, has emerged as a transformative force across multiple disciplines, particularly in medicine. Its unique physicochemical properties allow the design of nanoscale materials that improve diagnostics, therapeutics, and drug delivery systems. Nanomedicine, a pivotal branch of nanotechnology, focuses on precise targeting of drugs, controlled release, enhanced bioavailability, and improved imaging, ultimately enhancing disease management and patient outcomes. Over the past few decades, the rapid growth of research has facilitated the commercialization of various nanoparticle-based products, with drug delivery platforms comprising the largest market share. Nanoparticles, including liposomes, polymeric micelles, dendrimers, quantum dots, carbon nanotubes, nanoshells, nanobubbles, and solid lipid nanoparticles, offer distinct advantages such as biocompatibility, enhanced cellular uptake, targeted tissue accumulation, and the ability to cross biological barriers like the blood–brain barrier. Various fabrication methods-such as solvent evaporation, emulsification, ionic gelation, nano-spray drying, and supercritical fluid technology-allow precise control over particle size, surface characteristics, and drug encapsulation, enabling customization for specific therapeutic needs. Nanoparticle-based systems have demonstrated significant potential in treating cancer, neurodegenerative disorders, infectious diseases, chronic kidney disease, and in vaccine delivery, including COVID-19.

Keywords: Nanomedicine, Nanoparticles, Targeted drug delivery, Controlled release, Biocompatibility, Therapeutics

Keywords:

Nanomedicine, Nanoparticles, Targeted drug delivery, Controlled release, Biocompatibility, Therapeutics

DOI

https://doi.org/10.22270/jddt.v16i2.7557

Author Biographies

Shiv Kumar Srivastava , Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119

Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119

Mahesh Prasad , Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119

Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119

Shashi Shankar , Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119

Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119

Anant Prakash Pandey , Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119

Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119

Antesh Kumar Jha , Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119

Kamla Nehru Institute of Management and Technology, NH-96 Ayodhya–Prayagraj ByPass Road, Faridipur, Sultanpur (U.P.), India, PIN – 228119

References

1. Ranjbar L, Maleki A, Moradpoor H, Aghayan H. Nanotechnology: an overview and its applications. In: IIP Proceedings. Vol 2, Book 12, Part 1, Chapter 7. IIP Series; 2022. p. 98.

2. Bhushan B. Springer handbook of nanotechnology. 4th ed. Cham: Springer International Publishing; 2017. p. 1545-1550. https://doi.org/10.1007/978-3-662-54357-3

3. Malik S, Muhammad K, Waheed Y. Emerging applications of nanotechnology in healthcare and medicine. Molecules. 2023;28(18):6624. https://doi.org/10.3390/molecules28186624 PMid:37764400 PMCid:PMC10536529

4. Vyas SP, Khar RK. Targeted and controlled drug delivery: novel carrier systems. New Delhi: CBS Publishers & Distributors; 2018. p. 418.

5. Dang Y, Guan J. Nanoparticle-based drug delivery systems for cancer therapy. Smart Mater Med. 2020;1:10-19. https://doi.org/10.1016/j.smaim.2020.04.001 PMid:34553138 PMCid:PMC8455119

6. Geszke-Moritz M, Moritz M. Biodegradable polymeric nanoparticle-based drug delivery systems: comprehensive overview, perspectives and challenges. Polymers. 2024;16:2536. https://doi.org/10.3390/polym16172536 PMid:39274168 PMCid:PMC11397980

7. Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov. 2004;3(9):785-796. https://doi.org/10.1038/nrd1494 PMid:15340388

8. Saraiva C, Praça C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanoparticle-mediated brain drug delivery: overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release. 2016;235:34-47. https://doi.org/10.1016/j.jconrel.2016.05.044 PMid:27208862

9. Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2007;2(4):MR17-MR71. https://doi.org/10.1116/1.2815690 PMid:20419892

10. Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16:71. https://doi.org/10.1186/s12951-018-0392-8 PMid:30231877 PMCid:PMC6145203

11. Duan L, Li X, Ji R, et al. Nanoparticle-based drug delivery systems: an inspiring therapeutic strategy for neurodegenerative diseases. Polymers. 2023;15:2196. https://doi.org/10.3390/polym15092196 PMid:37177342 PMCid:PMC10181407

12. Iijima S. Helical microtubules of graphitic carbon. Nature. 1991;354(6348):56-58. https://doi.org/10.1038/354056a0

13. Murjani BO, Kadu PS, Bansod M, Vaidya SS, Yadav MD. Carbon nanotubes in biomedical applications: current status, promises, and challenges. Carbon Lett. 2022;32(5):1207-1226. https://doi.org/10.1007/s42823-022-00364-4 PMid:40477687 PMCid:PMC9252568

14. Gaur M, Misra C, Yadav AB, et al. Biomedical applications of carbon nanomaterials. Materials (Basel). 2021;14(20):5978. https://doi.org/10.3390/ma14205978 PMid:34683568 PMCid:PMC8538389

15. Iga AM, Robertson JH, Winslet MC, Seifalian AM. Clinical potential of quantum dots. Biomed Res Int. 2007;2007:76087. https://doi.org/10.1155/2007/76087 PMid:18317518 PMCid:PMC2254660

16. Lee JS, Youn YH, Kwon IK, et al. Recent advances in quantum dots for biomedical applications. J Pharm Investig. 2018;48:209-214. https://doi.org/10.1007/s40005-018-0387-3

17. Wagner AM, Knipe JM, Orive G, Peppas NA. Quantum dots in biomedical applications. Acta Biomater. 2019;94:44-63. https://doi.org/10.1016/j.actbio.2019.05.022 PMid:31082570 PMCid:PMC6642839

18. West JL, Halas NJ. Applications of nanotechnology to biotechnology. Curr Opin Biotechnol. 2000;11(2):215-217. https://doi.org/10.1016/S0958-1669(00)00082-3 PMid:10753774

19. Kalele SW, Gosavi S, Urban J, Kulkarni S. Nanoshell particles: synthesis, properties and applications. Curr Sci. 2006;91(8):1038-1052.

20. De Matteis V, Cascione M, Toma CC, Rinaldi R. Engineered gold nanoshells killing tumour cells. Curr Pharm Des. 2019;25(13). https://doi.org/10.2174/1381612825666190618155127 PMid:31258061

21. Topete A, Varela A, Navarro-Real M, et al. Revisiting gold nanoshells as multifunctional biomedical nanotools. Coord Chem Rev. 2025;523:216250. https://doi.org/10.1016/j.ccr.2024.216250

22. Eklund F, Alheshibri M, Swenson J. Differentiating bulk nanobubbles from nanodroplets and nanoparticles. Curr Opin Colloid Interface Sci. 2021;53:101427. https://doi.org/10.1016/j.cocis.2021.101427

23. Zhou J, Wang S, Zhang L, Hu J. Generation and stability of bulk nanobubbles. Curr Opin Colloid Interface Sci. 2021;53:101439. https://doi.org/10.1016/j.cocis.2021.101439

24. Xie X, Lin W, Liu H, et al. Ultrasound-responsive nanobubbles for targeted drug delivery. Drug Deliv. 2016;23(8):2756-2764. https://doi.org/10.3109/10717544.2015.1077289 PMid:26289216

25. Konnova S, Rozhina E. Magnetic nanoparticles for biomedical and imaging applications. Int J Mol Sci. 2024;25(11):5847. https://doi.org/10.3390/ijms25115847 PMid:38892034 PMCid:PMC11172554

26. Materón EM, Miyazaki CM, Carr O, et al. Magnetic nanoparticles in biomedical applications. Appl Surf Sci Adv. 2021;6:100163. https://doi.org/10.1016/j.apsadv.2021.100163

27. Nsairat H, Khater D, Sayed U, et al. Liposomes: structure, composition, types, and clinical applications. Heliyon. 2022;8(5):e09394. https://doi.org/10.1016/j.heliyon.2022.e09394 PMid:35600452 PMCid:PMC9118483

28. Sobol Ż, Chiczewski R, Wątróbska-Świetlikowska D. Advances in liposomal drug delivery. Pharmaceutics. 2025;17(7):885. https://doi.org/10.3390/pharmaceutics17070885 PMid:40733094 PMCid:PMC12298344

29. Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine. 2015;10:975-999. https://doi.org/10.2147/IJN.S68861 PMid:25678787 PMCid:PMC4324542

30. Chelliah R, Rubab M, Vijayalakshmi S, et al. Liposomes for drug delivery. Next Nanotechnol. 2025;8:100209. https://doi.org/10.1016/j.nxnano.2025.100209

31. Gabizon AA, Shmeeda H, Zalipsky S. Pros and cons of the liposome platform. J Liposome Res. 2006;16(3):175-183. https://doi.org/10.1080/08982100600848769 PMid:16952872

32. Wang S, Chen Y, Guo J, Huang Q. Liposomes for tumor targeted therapy. Int J Mol Sci. 2023;24(3):2643. https://doi.org/10.3390/ijms24032643 PMid:36768966 PMCid:PMC9916501

33. Moammeri A, Chegeni MM, Sahrayi H, et al. Current advances in niosomes applications for drug delivery and cancer treatment. Mater Today Bio. 2023;23:100837. https://doi.org/10.1016/j.mtbio.2023.100837 PMid:37953758 PMCid:PMC10632535

34. Gharbavi M, Amani J, Kheiri-Manjili H, Danafar H, Sharafi A. Niosome: a promising nanocarrier for natural drug delivery through blood-brain barrier. Adv Pharmacol Sci. 2018;2018:6847971. https://doi.org/10.1155/2018/6847971 PMid:30651728 PMCid:PMC6311792

35. Antonara L, Triantafyllopoulou E, Chountoulesi M, et al. Recent advances in niosome-based transdermal drug delivery systems. Curr Opin Biomed Eng. 2025;35:100603. https://doi.org/10.1016/j.cobme.2025.100603

36. Wang J, Li B, Qiu L, et al. Dendrimer-based drug delivery systems: history, challenges, and latest developments. J Biol Eng. 2022;16:18. https://doi.org/10.1186/s13036-022-00298-5 PMid:35879774 PMCid:PMC9317453

37. Chis AA, Dobrea C, Morgovan C, et al. Applications and limitations of dendrimers in biomedicine. Molecules. 2020;25(17):3982. https://doi.org/10.3390/molecules25173982 PMid:32882920 PMCid:PMC7504821

38. Alamos-Musre S, Beltrán-Chacana D, Moyano J, et al. From structure to function: the promise of PAMAM dendrimers in biomedical applications. Pharmaceutics. 2025;17:927. https://doi.org/10.3390/pharmaceutics17070927 PMid:40733135 PMCid:PMC12299782

39. Akiba I, Sakurai K. Characterizing block-copolymer micelles used in nanomedicines. Polym J. 2021;53:951-973. https://doi.org/10.1038/s41428-021-00489-9

40. Haladjova E, Rangelov S. Application of polymeric micelles for drug and gene delivery. Pharmaceutics. 2024;16(5):646. https://doi.org/10.3390/pharmaceutics16050646 PMid:38794308 PMCid:PMC11125079

41. Ghezzi M, Pescina S, Padula C, et al. Polymeric micelles in drug delivery. J Control Release. 2021;332:312-336. https://doi.org/10.1016/j.jconrel.2021.02.031 PMid:33652113

42. Begines B, Ortiz T, Pérez-Aranda M, et al. Polymeric nanoparticles for drug delivery. Nanomaterials. 2020;10(7):1403. https://doi.org/10.3390/nano10071403 PMid:32707641 PMCid:PMC7408012

43. Rodriguez-Cruz JJ, Chapa-Villarreal FA, Duggal I, Peppas NA. Advanced rational design of polymeric nanoparticles. J Control Release. 2025;384:113940. https://doi.org/10.1016/j.jconrel.2025.113940 PMid:40484283

44. Niu Y, Wu J, Kang Y, et al. Recent advances of magnetic chitosan hydrogel. Int J Biol Macromol. 2023;247:125722. https://doi.org/10.1016/j.ijbiomac.2023.125722 PMid:37419264

45. Eltaib L. Polymeric nanoparticles in targeted drug delivery. Polymers. 2025;17(7):833. https://doi.org/10.3390/polym17070833 PMid:40219222 PMCid:PMC11991310

46. Sultana F, Zare M, Thomas V, et al. Nano-based drug delivery systems. Med Drug Discov. 2022;15:100134. https://doi.org/10.1016/j.medidd.2022.100134

47. Arabestani MR, Bigham A, Kamarehei F, et al. Solid lipid nanoparticles in bacterial infections. Biomed Pharmacother. 2024;174:116433. https://doi.org/10.1016/j.biopha.2024.116433 PMid:38508079

48. Han H, Li S, Xu M, et al. Polymer- and lipid-based nanocarriers for ocular drug delivery. Adv Drug Deliv Rev. 2023;196:114770. https://doi.org/10.1016/j.addr.2023.114770 PMid:36894134

49. Reddy SH, Umashankar MS, Damodharan N. Solid lipid nanoparticles: a review. Res J Pharm Technol. 2018;11(12):5691-5700. https://doi.org/10.5958/0974-360X.2018.01031.4

50. Fahim M, Verma A, Faizan M. Nanoemulsions in novel drug delivery systems. J Pharmacogn Phytochem. 2024;13(5):562-567. https://doi.org/10.22271/phyto.2024.v13.i5h.15127

51. Kumar M, Chawla PA, Faruk A, et al. Solid self-nanoemulsifying drug delivery systems of nimodipine. Futur J Pharm Sci. 2024;10:87. https://doi.org/10.1186/s43094-024-00653-x

52. Miao Y, Zhao S, Zuo J, et al. Enhanced oral bioavailability using SNEDDS. Drug Des Devel Ther. 2022;16:1531-1546. https://doi.org/10.2147/DDDT.S356967 PMid:35637746 PMCid:PMC9143795

53. Zielińska A, Carreiró F, Oliveira AM, et al. Polymeric nanoparticles: production and toxicology. Molecules. 2020;25(16):3731. https://doi.org/10.3390/molecules25163731 PMid:32824172 PMCid:PMC7464532

54. Gillella S, M D, R S, et al. Polymeric nanoparticles - a review. J Innov Appl Pharm Sci. 2024;9(1):25-31. https://doi.org/10.37022/jiaps.v9i1.575

55. Hernández-Giottonini KY, Rodríguez-Córdova RJ, et al. PLGA nanoparticles by emulsification. RSC Adv. 2020;10:4218-4231. https://doi.org/10.1039/C9RA10857B PMid:35495261 PMCid:PMC9049000

56. Kothapalli VG, Vasanthan M. Solid lipid nanoparticles for oral absorption. Cureus. 2024;16(8):e68339. https://doi.org/10.1007/s12668-025-02277-8

57. Deng Y, Yang F, Zhao X, et al. Ibuprofen nanoparticles for skin penetration. Eur J Pharm Sci. 2018;114:293-302. https://doi.org/10.1016/j.ejps.2017.12.024 PMid:29288707

58. Halder A, Shukla D, Das S, et al. Lactoferrin-modified betulinic acid nanoparticles. Cytokine. 2018;110:412-415. https://doi.org/10.1016/j.cyto.2018.05.010 PMid:29784509

59. Silva BFB, Rodríguez-Abreu C, Vilanova N. Advances in multiple emulsions. Curr Opin Colloid Interface Sci. 2016;25:98-108. https://doi.org/10.1016/j.cocis.2016.07.006

60. Akram S, Anton N, Omran Z, Vandamme T. Water-in-oil nano-emulsions. Pharmaceutics. 2021;13:1030. https://doi.org/10.3390/pharmaceutics13071030 PMid:34371723 PMCid:PMC8309089

61. Piñón-Segundo E, Nava-Arzaluz MG, Lechuga-Ballesteros D. Double emulsion technique. Recent Pat Drug Deliv Formul. 2012;6(3):224-235. https://doi.org/10.2174/187221112802652606 PMid:22734870

62. Iqbal M, Zafar N, Fessi H, Elaissari A. Double emulsion solvent evaporation. Int J Pharm. 2015;496:173-190. https://doi.org/10.1016/j.ijpharm.2015.10.057 PMid:26522982

63. Geszke-Moritz M, Moritz M. Biodegradable polymeric nanoparticles. Polymers. 2024;16:2536. https://doi.org/10.3390/polym16172536 PMid:39274168 PMCid:PMC11397980

64. Piñón-Segundo E, Llera-Rojas VG, Leyva-Gómez G, et al. Emulsification-diffusion method. In: Grumezescu AM, editor. Pharmaceutical nanotechnology. 2018. p. 51-83. https://doi.org/10.1016/B978-0-12-813629-4.00002-4

65. Noriega-Peláez EK, Mendoza-Muñoz N, Ganem A, Quintanar D. Solvent displacement method. Drug Dev Ind Pharm. 2010;37(2):160-166. https://doi.org/10.3109/03639045.2010.501800 PMid:21073323

66. García-Salazar G, Zambrano-Zaragoza ML, Quintanar-Guerrero D. Nanodispersions using Venturi tube. Int J Pharm. 2018;545:254-260. https://doi.org/10.1016/j.ijpharm.2018.05.005 PMid:29729406

67. Fernández-Quiroz D, Tohidi MM, Paymard B, et al. Immobilization of essential oils. Stud Nat Prod Chem. 2023;78:365-401.

68. Wang H, Deng H, Gao M, Zhang W. Self-assembled nanogels. Front Bioeng Biotechnol. 2021;9:703559. https://doi.org/10.3389/fbioe.2021.703559 PMid:34336811 PMCid:PMC8322728

69. Mazayen ZM, Ghoneim AM, Elbatanony RS, et al. Pharmaceutical nanotechnology. Futur J Pharm Sci. 2022;8:12. https://doi.org/10.1186/s43094-022-00400-0 PMid:35071609 PMCid:PMC8760885

70. Chen D, Han S, Zhu Y, et al. Kidney-targeted nanoparticles. Int J Nanomedicine. 2018;13:3507-3527. https://doi.org/10.2147/IJN.S166445 PMid:29950832 PMCid:PMC6016261

71. Jiang B, Chen Z, Sun Y, et al. Superhydrophobic cotton fabrics. Appl Surf Sci. 2018;441:554-563. https://doi.org/10.1016/j.apsusc.2018.01.285

72. Hawkins M, Saha S, Ravindran E, Rathnayake H. Sol-gel polymerization method. J Polym Sci A. 2019;57(4):562-571. https://doi.org/10.1002/pola.29295

73. Umbarkar MG, Rindhe PS, Chandrawanshi SS, et al. Polymeric nanoparticles by nanoprecipitation. J Drug Deliv Ther. 2020;10(5-s):136-142. https://doi.org/10.22270/jddt.v10i5-s.4496

74. Kumoro AC, Wardhani DH, Kusworo TD, et al. Spray drying technology. J Hum Earth Future. 2024;5(2):279-305. https://doi.org/10.28991/HEF-2024-05-02-09

75. Arpagaus C, Collenberg A, Rütti D, et al. Nano spray drying for encapsulation. Int J Pharm. 2018;546:194-214. https://doi.org/10.1016/j.ijpharm.2018.05.037 PMid:29778825

76. Malamatari M, Charisi A, Malamataris S, et al. Spray drying for inhalation. Processes. 2020;8:788. https://doi.org/10.3390/pr8070788

77. Afonso IS, Cardoso B, Nobrega G, et al. Green synthesis of nanoparticles. J Environ Chem Eng. 2024;12(5):114022. https://doi.org/10.1016/j.jece.2024.114022

78. El-Naggar NEA, Shiha AM, Mahrous H, et al. Green synthesis of chitosan nanoparticles. Sci Rep. 2022;12:19869. https://doi.org/10.1038/s41598-022-24303-5 PMid:36400832 PMCid:PMC9674591

79. Roointan A, Xu R, Corrie S, et al. Nanotherapeutics in kidney disease. J Am Soc Nephrol. 2025;36(3):500-518. https://doi.org/10.1681/ASN.0000000608 PMid:39705082

80. Yang K, Shang Y, Yang N, et al. Nanoparticles in chronic kidney disease. Front Med (Lausanne). 2023;10:1132355. https://doi.org/10.3389/fmed.2023.1132355 PMid:37138743 PMCid:PMC10149997

81. Smith JP. Nanoparticle delivery of anti-tuberculosis chemotherapy. Yale J Biol Med. 2011;84(4):361-369.

82. Nair A, Greeny A, Nandan A, et al. Advanced strategies for tuberculosis treatment. J Nanobiotechnol. 2023;21:414. https://doi.org/10.1186/s12951-023-02156-y PMid:37946240 PMCid:PMC10634178

83. Sharma P, Prabhu A. Nanocarrier-mediated dermal drug delivery. IP Indian J Clin Exp Dermatol. 2025;11(1):10-21. https://doi.org/10.18231/j.ijced.2025.002

84. Krishnan V, Mitragotri S. Nanoparticles for topical drug delivery. Adv Drug Deliv Rev. 2020;153:87-108. https://doi.org/10.1016/j.addr.2020.05.011 PMid:32497707

85. Bhoyar V, Trivedi S, Gaikwad S, et al. Nanotechnology-based drug targeting. In: Rai M, Khan S, Belgamwar A, editors. Nanotechnology principles in drug targeting. Elsevier; 2023. p. 269-300. https://doi.org/10.1016/B978-0-323-91763-6.00007-2

86. Cao Y, Zhang R. Nanotechnology in Alzheimer's disease treatment. Front Bioeng Biotechnol. 2022;10:1042986. https://doi.org/10.3389/fbioe.2022.1042986 PMid:36466349 PMCid:PMC9713307

87. Ajith S, Almomani F, Elhissi A, Husseini GA. Nanoparticle-based anticancer delivery. Heliyon. 2023;9(11):e21227. https://doi.org/10.1016/j.heliyon.2023.e21227 PMid:37954330 PMCid:PMC10637937

88. Gomes HIO, Martins CSM, Prior JAV. Silver nanoparticles as anticancer carriers. Nanomaterials. 2021;11:964. https://doi.org/10.3390/nano11040964 PMid:33918740 PMCid:PMC8069134

89. Guerrini G, Magrì D, Gioria S, et al. Nanoparticle-based COVID-19 vaccines. Nat Nanotechnol. 2022;17:570-576. https://doi.org/10.1038/s41565-022-01129-w PMid:35710950

90. Prabhakar PK, Khurana N, Vyas M, et al. Nanotechnology for COVID-19 vaccine development. Pharmaceutics. 2023;15(2):451. https://doi.org/10.3390/pharmaceutics15020451 PMid:36839773 PMCid:PMC9960567

91. Jia Y, Jiang Y, He Y, et al. Approved nanomedicine against diseases. Pharmaceutics. 2023;15(3):774. https://doi.org/10.3390/pharmaceutics15030774 PMid:36986635 PMCid:PMC10059816

Published

2026-02-15
Statistics
Abstract Display: 211
PDF Downloads: 98
PDF Downloads: 78

How to Cite

1.
Srivastava SK, Prasad M, Shankar S, Pandey AP, Jha AK. From Molecules to Medicine: Nanotechnology Transforming Modern Therapeutics. J. Drug Delivery Ther. [Internet]. 2026 Feb. 15 [cited 2026 Jun. 4];16(2):29-40. Available from: https://jddtonline.info/index.php/jddt/article/view/7557

Issue

Vol. 16 No. 2 (2026): Volume 16, Issue 2, Jan 2026

Section

Review

Copyright (c) 2026 Shiv Kumar Srivastava , Mahesh Prasad , Shashi Shankar , Anant Prakash Pandey , Antesh Kumar Jha

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

How to Cite

1.
Srivastava SK, Prasad M, Shankar S, Pandey AP, Jha AK. From Molecules to Medicine: Nanotechnology Transforming Modern Therapeutics. J. Drug Delivery Ther. [Internet]. 2026 Feb. 15 [cited 2026 Jun. 4];16(2):29-40. Available from: https://jddtonline.info/index.php/jddt/article/view/7557
Crossref
Scopus
Google Scholar
Europe PMC